Squarepoint Ops LLC has significantly reduced its holdings in PACCAR Inc. by 26.5% during the second quarter, now owning 422,325 shares valued at $50.73 million. This move comes as other hedge funds have either purchased new positions or boosted their stakes in PACCAR. Insider activity also shows recent sales by CFO Brice J. Poplawski and VP William Lance Walters.

Maven Securities LTD has made a new investment of approximately $6 million in Williams-Sonoma, Inc. ($WSM), purchasing 25,754 shares during the second quarter. This move aligns with a broader trend of institutional ownership, as hedge funds and institutional investors collectively own 99.29% of the company's stock. Williams-Sonoma continues to show strong financial performance, exceeding quarterly expectations with $2.10 EPS and $1.96 billion in revenue, alongside a positive analyst sentiment and a declared quarterly dividend.

NewEdge Advisors LLC increased its stake in The TJX Companies, Inc. by 2.1% in Q2, holding over one million shares valued at $158.65 million. Despite recent analyst downgrades, TJX holds a "Moderate Buy" consensus rating with an average price target of $171.63, and the company exceeded Q2 earnings and revenue expectations, guiding positively for fiscal 2027.

Maven Securities LTD recently acquired 23,775 shares of O'Reilly Automotive, Inc. (NASDAQ:ORLY) worth approximately $2.19 million, contributing to institutional investors owning about 85% of the company. Analysts maintain a "Moderate Buy" consensus rating for ORLY, with a target price of $107.24. The company reported strong quarterly revenue of $4.89 billion and adjusted earnings of $0.86 per share, while insider selling accounted for 6,000 shares valued at about $550,530 over the past 90 days.

Revvity, Inc. announced its definitive agreement to acquire Human Cell Design, a French biotechnology company specializing in human cell models for diabetes, obesity, and metabolic disease research. This acquisition will integrate Human Cell Design's advanced cell models, including the EndoC-βH5 human pancreatic beta cell model, into Revvity's Life Sciences portfolio to enhance drug discovery and preclinical research efforts. The deal is expected to close in Q4 2026, pending regulatory approvals, with financial terms remaining undisclosed.

The California State Teachers Retirement System significantly increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 5,484.7% in the second quarter, now holding over 185 million shares worth approximately $10.67 billion. This comes as other hedge funds also adjusted their positions, and Wall Street analysts have offered mixed ratings on the stock, with a consensus target price of $66.06. Bristol Myers Squibb recently reported strong quarterly earnings, surpassing analyst expectations, and announced a quarterly dividend.

Hsbc Holdings PLC significantly increased its stake in Versant Corporation (NASDAQ:VSNT) by 154.1% in the second quarter, acquiring an additional 268,740 shares. This brings their total holdings to 443,145 shares, valued at approximately $16.08 million. Other institutional investors have also made moves in Versant stock, which currently holds an average "Hold" rating from analysts with an average price target of $43.20.

UBS Group AG has announced that it has ceased to be a substantial shareholder in MAAS Group Holdings Ltd. as of September 7, 2026, reducing its stake in the company. This shift in institutional investor base may influence market perceptions of MAAS Group’s stock. The current analyst rating for MAAS Group Holdings is a Buy with a price target of A$6.49.

The California State Teachers Retirement System significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 8,327.8% during the second quarter, now holding over 107 million shares valued at approximately $9.81 billion. This makes the system a major institutional holder, owning about 13.43% of the company's stock. The article also details other hedge fund activities, recent analyst ratings, financial performance metrics, dividend information, and insider trading activities for Colgate-Palmolive.

Baird Financial Group Inc. decreased its stake in Procter & Gamble (NYSE:PG) by 0.5% in the second quarter, now holding 1,538,711 shares valued at $225.6 million. Despite this, several other institutional investors increased their positions in P&G, and the company recently announced a quarterly dividend of $1.0885 per share. Analysts have a "Moderate Buy" consensus rating for P&G with an average price target of $161.19.